Source: International Congress 2019 – Advances in clinical management of COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Montes De Oca (Caracas, Venezuela), A. Menezes (Pelotas, Brazil), F. Wehrmeister (Pelotas, Brazil), V. Lopez (Montevideo, Uruguay), L. Ramirez (San Jose, Costa Rica), M. Miravtlles (Barcelona, Spain). Evaluation Of 24-Hour Day Respiratory Symptoms And GOLD Classification System In COPD Patients From Seven Latin America Countries: The LASSYC Study. 3887

Member's Comments

No comment yet.

Related content which might interest you: Evaluation of COPD Patient’s Relatives Assessment of Disease Awarness, Load of Care Giving and Loss of Workforce: Turkish Thoracic Society COPD Working Group. Source: International Congress 2018 – Patient-reported outcomes and scores in COPD Year: 2018 European Respiratory Society Guidelines for the Diagnosis of Asthma in Adults Source: Guideline 2022 Year: 2022 Late Breaking Abstract - Validation of the REVEAL 2.0 Risk Score with the Australian and New Zealand Pulmonary Hypertension Registry Cohort. Source: International Congress 2019 – Endpoints and risk assessment of pulmonary arterial hypertension Year: 2019 Agreement Between COPD Assessment Test (CAT) And Modified Medical Research Council (mMRC) Dyspnea Scores For GOLD COPD Classification: A Cross-Sectional Analyses Source: International Congress 2019 – Clinical implications of COPD management Year: 2019 Comparison of Eosinophilic and Non-eosinophilic Cases with Chronic Obstructive Pulmonary Disease (COPD) in terms of Clinical Arrival, Exacerbations, Quality of Life and Response to Treatment: A Prospective Study Source: International Congress 2019 – Airway diseases and blood cells Year: 2019 Study to Evaluate Satisfaction with the Inhalation Device Used by Patients with Asthma or Chronic Obstructive Pulmonary Disease and the Association with Adherence and Disease Control Source: Virtual Congress 2020 – Novel insights into nursing interventions for managing patients with asthma and COPD Year: 2020 Estimating Chronic Respiratory Disease (Asthma and COPD) burden in adults in Asian LMICs: a pilot study for 4CCORD [4 Country ChrOnic Respiratory Disease study]. Source: Virtual Congress 2020 – Exhaled biomarkers of asthma and the asthma burden Year: 2020 International ERS/ATS Guidelines on Definition, Evaluation and Treatment of Severe Asthma Source: Guideline 2014 Year: 2014 Evaluation of 30 and 90 Day Hospital Readmission Rates in Severe COPD Exacerbations: Turkish Thoracic Society COPD Assembly Source: Virtual Congress 2020 – Monitoring of patients with COPD Year: 2020 Late Breaking Abstract - Characteristics of Patients Diagnosed with Severe Asthma at UK Specialist Centres: Variation by Ethnicity Source: International Congress 2019 – Bronchiectasis Year: 2019 Real World Effects of Medications for COPD - a UK Population-Based Non-Interventional Cohort Study With Validation Against Randomised Trial Results Source: International Congress 2019 – COPD treatment: cohorts and real-world studies Year: 2019 Assessment of Severe Asthma Management Practices among Pulmonologists and Allergists Source: International Congress 2018 – Medical education via the web and the internet Year: 2018 The Effect Of An Active Exercise Program Combined With Chest Physiotherapy On Pain Severity,Posture, Respiratory Function And Quality Of Life In Patients With Chronic Obstructive Pulmonary Disease. Source: International Congress 2019 – Exercise and rehabilitation in patients with acute and chronic respiratory diseases Year: 2019 “Patients Included” in the European Respiratory Society International Congress Source: Breathe 2015; 11: 249-254 Year: 2015 Late Breaking Abstract - Real-World Characteristics of Patients Receiving Dupilumab in Routine Clinical Practice in a Multinational, Non-Interventional Study (ProVENT) Source: Virtual Congress 2021 – Airway pharmacology: translational and basic science Year: 2021 Health Related Quality of Life in children with Paediatric Central Airway Obstructive Disease (PCAOD) assessed by PACQLQ and TAPQOL questionnaires Source: International Congress 2017 – Paediatric bronchology in clinical practice Year: 2017 The Impact of Multimorbidity on Hospitalizations in Patients with Chronic Obstructive Pulmonary Disease (COPD): a Population-Based Study Source: International Congress 2019 – Airway disease-associated exacerbations Year: 2019 The Impact of Air Pollution, Including Asian Sand Dust, on Respiratory Symptoms and Health-related Quality of Life in Outpatients With Chronic Respiratory Disease in Korea Source: International Congress 2019 – Air pollution and the lungs Year: 2019 Dupilumab Efficacy in Type 2 Inflammatory Asthma: Liberty Asthma QUEST Study Source: International Congress 2019 – Precision meets immunology in treatment of airway diseases Year: 2019 European Respiratory Society Guideline on Long-term Home Non-Invasive Ventilation for Management of Chronic Obstructive Pulmonary Disease Source: Guideline 2019 Year: 2019